Faron Pharmaceuticals Oy (FARN) Competitors GBX 195 +2.50 (+1.30%) (As of 12/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines FARN vs. ERGO, SLN, OXB, PRTC, HZD, VRP, BVXP, ARIX, AVCT, and 4BBShould you be buying Faron Pharmaceuticals Oy stock or one of its competitors? The main competitors of Faron Pharmaceuticals Oy include Ergomed (ERGO), Silence Therapeutics (SLN), Oxford Biomedica (OXB), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Bioventix (BVXP), Arix Bioscience (ARIX), Avacta Group (AVCT), and 4basebio (4BB). These companies are all part of the "biotechnology" industry. Faron Pharmaceuticals Oy vs. Ergomed Silence Therapeutics Oxford Biomedica PureTech Health Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Bioventix Arix Bioscience Avacta Group 4basebio Faron Pharmaceuticals Oy (LON:FARN) and Ergomed (LON:ERGO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation, community ranking and media sentiment. Does the media prefer FARN or ERGO? In the previous week, Faron Pharmaceuticals Oy had 2 more articles in the media than Ergomed. MarketBeat recorded 2 mentions for Faron Pharmaceuticals Oy and 0 mentions for Ergomed. Ergomed's average media sentiment score of 0.00 beat Faron Pharmaceuticals Oy's score of -0.07 indicating that Ergomed is being referred to more favorably in the news media. Company Overall Sentiment Faron Pharmaceuticals Oy Neutral Ergomed Neutral Does the MarketBeat Community favor FARN or ERGO? Faron Pharmaceuticals Oy received 75 more outperform votes than Ergomed when rated by MarketBeat users. Likewise, 77.51% of users gave Faron Pharmaceuticals Oy an outperform vote while only 75.63% of users gave Ergomed an outperform vote. CompanyUnderperformOutperformFaron Pharmaceuticals OyOutperform Votes31777.51% Underperform Votes9222.49% ErgomedOutperform Votes24275.63% Underperform Votes7824.38% Which has more risk and volatility, FARN or ERGO? Faron Pharmaceuticals Oy has a beta of 0.36, suggesting that its stock price is 64% less volatile than the S&P 500. Comparatively, Ergomed has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500. Do institutionals & insiders have more ownership in FARN or ERGO? 10.7% of Faron Pharmaceuticals Oy shares are owned by institutional investors. Comparatively, 71.1% of Ergomed shares are owned by institutional investors. 31.8% of Faron Pharmaceuticals Oy shares are owned by insiders. Comparatively, 18.2% of Ergomed shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has higher earnings and valuation, FARN or ERGO? Ergomed has higher revenue and earnings than Faron Pharmaceuticals Oy. Faron Pharmaceuticals Oy is trading at a lower price-to-earnings ratio than Ergomed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFaron Pharmaceuticals Oy-£725K-281.39-£31.61M-£0.32-609.38Ergomed£152.09M4.61£15M£0.294,641.38 Is FARN or ERGO more profitable? Ergomed has a net margin of 9.87% compared to Faron Pharmaceuticals Oy's net margin of 0.00%. Ergomed's return on equity of 18.08% beat Faron Pharmaceuticals Oy's return on equity.Company Net Margins Return on Equity Return on Assets Faron Pharmaceuticals OyN/A N/A -70.00% Ergomed 9.87%18.08%10.16% SummaryErgomed beats Faron Pharmaceuticals Oy on 11 of the 15 factors compared between the two stocks. Ad Porter & CompanyFirst JFK… next Elon?Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. Get Faron Pharmaceuticals Oy News Delivered to You Automatically Sign up to receive the latest news and ratings for FARN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FARN vs. The Competition Export to ExcelMetricFaron Pharmaceuticals OyBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£204.01M£127.71M£5.26B£1.41BDividend YieldN/A3.69%5.33%11.94%P/E Ratio-609.38191.13122.251,539.05Price / Sales-281.3917,797.241,289.58392,710.40Price / Cash20.0012.0242.8432.78Price / Book195.008.174.832.95Net Income-£31.61M-£13.04M£119.60M£130.48M7 Day Performance16.42%1.56%3.27%9.82%1 Month Performance25.00%10.19%2.65%9.83%1 Year Performance-26.69%26.10%32.74%107.79% Faron Pharmaceuticals Oy Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FARNFaron Pharmaceuticals OyN/AGBX 195+1.3%N/A-23.1%£204.01M£-725,000.00-609.3834News CoverageGap UpERGOErgomedN/AGBX 1,346flatN/A+0.0%£701.00M£152.09M4,641.386SLNSilence TherapeuticsN/AN/AN/A+0.0%£480.35M£11.35M-11.01100High Trading VolumeOXBOxford BiomedicaN/AGBX 425.50-0.7%GBX 433.33+1.8%+145.7%£448.31M£97.28M-295.49891PRTCPureTech HealthN/AGBX 167.40+0.4%N/A+11.7%£400.79M£3.33M-715.20300Gap UpHZDHorizon Discovery Group plc (HZD.L)N/AGBX 184.50flatN/AN/A£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AGBX 55+5.8%N/AN/A£228MN/A-1.6822Gap UpBVXPBioventixN/AGBX 3,750+1.4%N/A-4.5%£195.75M£13.60M2,269.9412News CoverageGap UpARIXArix BioscienceN/AN/AN/A+27.6%£183.73M£14.16M1,290.919AVCTAvacta GroupN/AGBX 47-2.5%N/A-65.5%£168.40M£22.62M-522.22120Gap Up4BB4basebioN/AGBX 1,304+0.3%N/A+124.9%£167.04M£311,000.00-1,671.79101 Related Companies and Tools Related Companies Ergomed Alternatives Silence Therapeutics Alternatives Oxford Biomedica Alternatives PureTech Health Alternatives Horizon Discovery Group plc (HZD.L) Alternatives Verona Pharma plc (VRP.L) Alternatives Bioventix Alternatives Arix Bioscience Alternatives Avacta Group Alternatives 4basebio Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:FARN) was last updated on 12/5/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredLock in this share price before 12/5When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...Pacaso | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Faron Pharmaceuticals Oy Please log in to your account or sign up in order to add this asset to your watchlist. Share Faron Pharmaceuticals Oy With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
